Summary
In vitro stability of the lysosomal membrane complex was studied in non-pregnant human uterine cervices. The oestrogen therapy caused markedly enhanced lability of the lysosomal membrane complex as evidenced by higher activity of the “marker” enzyme when the preparations were challenged by mechanical or detergent stress.
Oestradiol-17β might be implicated in altering the metabolism of the proteoglycan complex which may result in the “ripening” of the pregnant cervix.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buddecke E, Kresse H (1974) Mammalian enzymes degrading glycosaminoglycans. In: Fricke R, Hartman F (eds) Connective tissues — biochemistry and pathophysiology. Springer Verlag, Berlin Heidelberg New York, p 131
Linhardt K, Walter K (1965) Phosphatases (phosphomonoesterases). Methods Biochem Anal 88: 779–787
Hartree EF (1972) Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422–427
Joh K, Riede UN, Zahradnik HP (1983) The effect of prostaglandins on the lysosomal function in the cervix uteri. Arch Gynecol 234: 1–16
Wallis RM, Hillier K (1981) Regulation of collagen dissolution in the human cervix by oestradiol-17β and progesterone J Reprod Fertil 62: 55–61
Weismann G, Thomas L (1963) Studies on lysosomes. II. The effects of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest 42: 661–669
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herczeg, J., Borsodi, A. Increased lysosomal fragility in the human uterine cervix following estrogen therapy. Arch. Gynecol. 236, 131–133 (1985). https://doi.org/10.1007/BF02133955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02133955